This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: 89Bio, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Hank Mansbach: Innovator in Hypertriglyceridemia Treatment
Introduction
Hank Mansbach is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of medical treatments, particularly focusing on severe hypertriglyceridemia. His innovative work has led to the development of therapeutic methods that aim to improve patient outcomes.
Latest Patents
Hank Mansbach holds a patent for "Compositions and methods of treatment for severe hypertriglyceridemia." This patent includes compositions, methods, and therapeutic regimens involving mutant Fibroblast Growth Factor-21 (FGF-21) peptide conjugates. These advancements are crucial for treating individuals suffering from this condition.
Career Highlights
Mansbach is currently associated with 89Bio, Inc., a company dedicated to developing innovative therapies for metabolic diseases. His role at the company allows him to leverage his expertise in creating effective treatment options.
Collaborations
Hank collaborates with various professionals in the field, including his coworker Leo Tseng. Their combined efforts contribute to the advancement of medical treatments and research.
Conclusion
Hank Mansbach's work in the treatment of severe hypertriglyceridemia showcases his dedication to innovation in medicine. His contributions are paving the way for improved therapeutic options for patients in need.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile